Variation in topoisomerase I gene copy number as a mechanism for intrinsic drug sensitivity
1996

Topoisomerase I Gene Copy Number and Drug Sensitivity

Sample size: 5 publication Evidence: moderate

Author Information

Author(s): HL McLeod, WN Keith

Primary Institution: University of Glasgow

Hypothesis

Altered topoisomerase I gene copy number affects intrinsic drug sensitivity in cancer cell lines.

Conclusion

The study demonstrates a significant relationship between topoisomerase I gene copy number, protein expression, and cellular sensitivity to the drug SN38.

Supporting Evidence

  • Topoisomerase I gene copy number varied from 1 to 6 in the studied cell lines.
  • Topo I expression was highly correlated with gene copy number (r=0.92).
  • Intrinsic sensitivity to SN38 was inversely related to topo I gene copy number (r=-0.904).

Takeaway

This study found that cancer cells with more copies of a specific gene are less sensitive to a drug that targets that gene, which helps explain why some tumors resist treatment.

Methodology

Fluorescence in situ hybridization was used to detect topoisomerase I gene copies in breast and colon cancer cell lines, and cytotoxicity was assessed using the MTT assay.

Limitations

The study focused on a limited number of cell lines and may not represent all tumor types.

Participant Demographics

The study included four breast cancer cell lines and one colon cancer cell line.

Statistical Information

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication